BCO Fundamental Analysis - BOEING CO/THE

Fundamental Rating

BCO gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 54 industry peers in the Aerospace & Defense industry. BCO may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, BCO is valued expensive at the moment.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year BCO has reported negative net income.
BCO had a negative operating cash flow in the past year.
In the past 5 years BCO always reported negative net income.
In multiple years BCO reported negative operating cash flow during the last 5 years.

1.2 Ratios

BCO's Return On Assets of -6.78% is on the low side compared to the rest of the industry. BCO is outperformed by 88.89% of its industry peers.

		Industry Rank	Sector Rank
ROA	-6.78%
ROE	N/A
ROIC	N/A

ROA(3y)-4.27%

ROA(5y)-4.73%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

BCO's Gross Margin of 1.10% is on the low side compared to the rest of the industry. BCO is outperformed by 90.74% of its industry peers.
The Profit Margin and Operating Margin are not available for BCO so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	1.1%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

BCO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BCO has more shares outstanding
The number of shares outstanding for BCO has been increased compared to 5 years ago.
BCO has a better debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 1.30, we must say that BCO is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.30, BCO is not doing good in the industry: 83.33% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	1.3

ROIC/WACCN/A

WACC8.9%

2.3 Liquidity

BCO has a Current Ratio of 1.18. This is a normal value and indicates that BCO is financially healthy and should not expect problems in meeting its short term obligations.
BCO has a Current ratio (1.18) which is comparable to the rest of the industry.
BCO has a Quick Ratio of 1.18. This is a bad value and indicates that BCO is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.38, BCO is doing worse than 92.59% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	1.18
Quick Ratio	0.38

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for BCO have decreased by -1.07% in the last year.
Looking at the last year, BCO shows a quite strong growth in Revenue. The Revenue has grown by 10.18% in the last year.
The Revenue has been decreasing by -4.74% on average over the past years.

EPS 1Y (TTM)-1.07%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%28.45%

Revenue 1Y (TTM)10.18%

Revenue growth 3Y2.21%

Revenue growth 5Y-4.74%

Sales Q2Q%30.44%

3.2 Future

The Earnings Per Share is expected to grow by 20.82% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 14.32% on average over the next years. This is quite good.

EPS Next Y51.61%

EPS Next 2Y44.69%

EPS Next 3Y31.63%

EPS Next 5Y20.82%

Revenue Next Year30.29%

Revenue Next 2Y19.82%

Revenue Next 3Y17.51%

Revenue Next 5Y14.32%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BCO. In the last year negative earnings were reported.
BCO is valuated quite expensively with a Price/Forward Earnings ratio of 129.76.
83.33% of the companies in the same industry are cheaper than BCO, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 24.29. BCO is valued rather expensively when compared to this.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	129.76

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as BCO's earnings are expected to grow with 31.63% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y44.69%

EPS Next 3Y31.63%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

BCO does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

BOEING CO/THE

FRA:BCO (1/16/2026, 7:00:00 PM)

212.5

-0.55 (-0.26%)

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCapital Goods

GICS IndustryAerospace & Defense

Earnings (Last)10-29 2025-10-29/bmo

Earnings (Next)01-27 2026-01-27/amc

Inst Owners71.79%

Inst Owner ChangeN/A

Ins Owners0.03%

Ins Owner ChangeN/A

Market Cap161.52B

Revenue(TTM)80.76B

Net Income(TTM)-10.17B

Analysts83.78

Price Target222.26 (4.59%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)-19.63%

Min EPS beat(2)-57.93%

Max EPS beat(2)18.67%

EPS beat(4)2

Avg EPS beat(4)-16.78%

Min EPS beat(4)-91.07%

Max EPS beat(4)63.2%

EPS beat(8)5

Avg EPS beat(8)-3.37%

EPS beat(12)6

Avg EPS beat(12)-66.45%

EPS beat(16)6

Avg EPS beat(16)-757.66%

Revenue beat(2)2

Avg Revenue beat(2)1.97%

Min Revenue beat(2)1.11%

Max Revenue beat(2)2.82%

Revenue beat(4)2

Avg Revenue beat(4)-1.87%

Min Revenue beat(4)-8.71%

Max Revenue beat(4)2.82%

Revenue beat(8)3

Avg Revenue beat(8)-1.85%

Revenue beat(12)4

Avg Revenue beat(12)-1.59%

Revenue beat(16)4

Avg Revenue beat(16)-4.27%

PT rev (1m)2.49%

PT rev (3m)-2.39%

EPS NQ rev (1m)-0.3%

EPS NQ rev (3m)-951.41%

EPS NY rev (1m)-0.06%

EPS NY rev (3m)-303.47%

Revenue NQ rev (1m)0.92%

Revenue NQ rev (3m)-0.5%

Revenue NY rev (1m)0.08%

Revenue NY rev (3m)1.86%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	129.76
P/S	2.32
P/FCF	N/A
P/OCF	N/A
P/B	N/A
P/tB	N/A
EV/EBITDA	N/A

EPS(TTM)-13

EYN/A

EPS(NY)1.64

Fwd EY0.77%

FCF(TTM)-7.19

FCFYN/A

OCF(TTM)-4.21

OCFYN/A

SpS91.46

BVpS-9.34

TBVpS-19.28

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-6.78%
ROE	N/A
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	1.1%
FCFM	N/A

ROA(3y)-4.27%

ROA(5y)-4.73%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score4

Asset Turnover0.54

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	136.76%
Cap/Sales	3.26%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.18
Quick Ratio	0.38
Altman-Z	1.3

F-Score4

WACC8.9%

ROIC/WACCN/A

Cap/Depr(3y)90.02%

Cap/Depr(5y)74.76%

Cap/Sales(3y)2.43%

Cap/Sales(5y)2.22%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-1.07%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%28.45%

EPS Next Y51.61%

EPS Next 2Y44.69%

EPS Next 3Y31.63%

EPS Next 5Y20.82%

Revenue 1Y (TTM)10.18%

Revenue growth 3Y2.21%

Revenue growth 5Y-4.74%

Sales Q2Q%30.44%

Revenue Next Year30.29%

Revenue Next 2Y19.82%

Revenue Next 3Y17.51%

Revenue Next 5Y14.32%

EBIT growth 1Y-25.36%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year75.84%

EBIT Next 3Y48.05%

EBIT Next 5Y31.28%

FCF growth 1Y-237.62%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-161.56%

OCF growth 3YN/A

OCF growth 5YN/A

BOEING CO/THE / BCO.DE FAQ

Can you provide the ChartMill fundamental rating for BOEING CO/THE?

ChartMill assigns a fundamental rating of 1 / 10 to BCO.DE.

What is the valuation status for BCO stock?

ChartMill assigns a valuation rating of 1 / 10 to BOEING CO/THE (BCO.DE). This can be considered as Overvalued.

What is the profitability of BCO stock?

BOEING CO/THE (BCO.DE) has a profitability rating of 0 / 10.

Can you provide the financial health for BCO stock?

The financial health rating of BOEING CO/THE (BCO.DE) is 1 / 10.

BOEING CO/THE (BCO.DE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

BOEING CO/THE / BCO.DE FAQ

Can you provide the ChartMill fundamental rating for BOEING CO/THE?

What is the valuation status for BCO stock?

What is the profitability of BCO stock?

Can you provide the financial health for BCO stock?